MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO)

FDA Device Recall #Z-1078-2026 - Class II, December 10, 2025

Recall Summary

Recall Number Z-1078-2026
Classification Class II - Moderate risk
Date Initiated December 10, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Elekta, Inc.
Location Atlanta, GA
Product Type Devices
Quantity 1

Product Description

MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO)

Reason for Recall

Using oncology information system that manages workflow may result in overtreatment if:Plan delivered with Particle Therapy IHE-RO TDW-II interface,With one field per fraction or last field partial treatment,Partial treatment occurs followed by treatment field interruptions with manually recorded partial treatment,Then treatment unit doesn't check meterset value so partial treatment delivered twice

Distribution Pattern

US Nationwide distribution in the state of TX.

Lot / Code Information

MOSAIQ v 3.10.200, and 3.1.1.0 up to and including v 3.2.3.1 with Particle Base. Software Versions: 3.10.200, 3.1.1.0, 3.1.2.0, 3.1.3.0, 3.1.3.1, 3.1.3.2, 3.1.3.3, 3.1.3.4, 3.2.0.0, 3.2.1.0, 3.2.1.1, 3.2.1.2, 3.2.1.3, 3.2.1.4, 3.2.2.0, 3.2.2.1, 3.2.3.0, 3.2.3.1 UDI-DI: 07340201500026, 07340201500071

Other Recalls from Elekta, Inc.

Recall # Classification Product Date
Z-2406-2026 Class II MOSAIQ Oncology Information System May 21, 2026
Z-2710-2026 Class II Brand Name: Fletcher CT/MR Shielded Applicator ... Apr 3, 2026
Z-2712-2026 Class II Brand Name: Geneva Product Name: Brachytherapy... Apr 3, 2026
Z-2711-2026 Class II Brand Name: Brachytherapy Applicator Product N... Apr 3, 2026
Z-2006-2026 Class II Brand Name: Leksell Vantage Arc System REF: 10... Mar 19, 2026

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.